Metformin is generally recommended as a first line treatment as there is some evidence that it decreases mortality; however, this conclusion is questioned.
Metformiin on üldiselt soovitatav, kui esimese ravimina, kuna on tõendeid, et see vähendab suremust, aga see järeldus on kahtluse all.